GTHP GUIDED THERAPEUTICS INC

MIXED Impact: 5/10 8-K
Horizon weeks Filed Mar 10, 2026 Processed 3mo ago SEC 0001477932-26-001252
Killer combo: Material agreement + unregistered equity (likely PIPE/convertible)
Final — all horizons settled through T+60d
GTHP ▼ -21.38% at T+60d
NEUTRAL call ✗ call lost -21.38% · α vs SPY -33.06% · entry $0.2900 → $0.2280
Last close $0.2000 (close Jun 8) · -31.03% from $0.2900 entry
Entry anchored
Mar 10, 2026
via day open
T+1d
0.00%
call 0.00% · α +0.10%
$0.2900
settled 3mo ago
T+5d
-3.45%
call -3.45% · α -2.54%
$0.2800
settled 3mo ago
T+20d
-17.24%
call -17.24% · α -17.09%
$0.2400
settled 2mo ago
T+60d
-21.38%
call -21.38% · α -33.06%
$0.2280
settled 6d ago

Price Chart

Loading chart...

Executive Summary

Guided Therapeutics completed a warrant exchange, issuing 4.825 million new shares and raising $980,000 in cash. The exchange reduced warrant overhang but increased share count from 86.7 million to 91.5 million. Most warrants (16.4 million) remain outstanding with expirations in 2026-2027.

Key Financial Metrics

Deal Value
$980.0K

Actionable Insight

Monitor upcoming warrant expirations in September-October 2026 and 2027 which could lead to additional dilution or cash inflows. The cash infusion provides near-term runway but the ongoing warrant overhang remains a shareholder dilution risk.

Key Facts

  • Completed warrant exchange on March 2, 2026, with 4.825 million warrants exercised (22.7% of eligible warrants)
  • Raised $980,000 in cash from warrant exercises
  • Issued 4.825 million new shares, increasing outstanding shares from 86,691,976 to 91,516,976
  • Remaining 16,398,080 warrants outstanding with expirations in 2026-2027
  • Warrants originally priced at $0.65 and $0.50 were exercised at discounted prices of $0.25 and $0.20 respectively

Financial Impact

$980,000 cash raised with 5.6% share dilution (4.825M new shares on 86.7M base)

cashshares_outstandingdilution

Risk Factors

  • Further significant dilution when remaining 16.4 million warrants expire in 2026-2027
  • Potential downward pressure on stock price from increased float
  • Limited cash raised ($980,000) may not substantially extend operational runway

Market Snapshot

Exchange
OTC

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001477932-26-001252
Document: 0001477932-26-001252-index-headers.html0001477932-26-001252
Document: 0001477932-26-001252-index.html0001477932-26-001252
Document: 0001477932-26-001252.txt0001477932-26-001252

US Market Status

Market Closed — Opens in 6h 52m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access